| Dec'19 | Dec'18 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | |
|---|---|---|---|---|---|---|
Revenue from Contract with Customer, Including Assessed Tax | ||||||
1,831,400 | 1,771,500 | 1,145,438 | 959,891 | 403,289 | 284,599 | |
Operating expenses: | ||||||
Salaries and benefits | ||||||
550,000 | 534,700 | - | 261,685 | 101,976 | 70,923 | |
Supplies | ||||||
507,900 | 490,300 | - | 242,083 | 94,224 | 63,726 | |
Professional and medical fees | ||||||
154,800 | 145,500 | - | 66,583 | 18,028 | 7,372 | |
Lease expense | ||||||
85,600 | 86,700 | - | 44,848 | 19,389 | 14,048 | |
Other operating expenses | ||||||
109,300 | 104,200 | - | 54,127 | 20,561 | 13,775 | |
Cost of revenues | ||||||
1,407,600 | 1,361,400 | - | 669,326 | 254,178 | 169,844 | |
Total operating expenses | ||||||
1,595,500 | 1,693,700 | - | - | - | - | |
General and administrative expenses | ||||||
88,600 | 93,600 | - | 55,992 | 31,452 | 26,339 | |
Depreciation, Depletion and Amortization | ||||||
76,500 | 67,400 | - | 34,545 | 15,061 | 11,663 | |
Provision for doubtful accounts (see Note 1) | ||||||
0 | 0 | - | 23,578 | 9,509 | 5,885 | |
Income from equity investments | ||||||
10,200 | 8,900 | - | 3,777 | 1,264 | 0 | |
Gain (Loss) On Disposition Of Assets And Deconsolidation | ||||||
4,400 | -31,800 | - | 2,097 | -1,804 | -2,482 | |
Transaction and integration costs | ||||||
19,000 | 31,700 | - | 17,920 | 21,690 | 0 | |
Impairment charges | ||||||
7,900 | 74,400 | - | - | - | - | |
Loss on debt extinguishment | ||||||
-11,700 | 0 | - | -16,102 | -23,414 | -9,863 | |
Litigation settlement | ||||||
-200 | -46,000 | - | 0 | 0 | - | |
Gain on acquisition escrow release | ||||||
0 | 0 | - | - | - | - | |
Termination of management agreement and IPO costs | ||||||
- | - | - | 5,834 | 0 | 0 | |
Electronic health records incentive expense (income) | ||||||
- | - | - | 1,761 | 3,356 | 0 | |
Other income | ||||||
-1,400 | -3,700 | - | -525 | -6 | 297 | |
Total operating expenses | ||||||
- | - | - | 815,137 | 352,482 | 226,373 | |
Operating income | ||||||
235,900 | 77,800 | - | 144,754 | 50,807 | 58,226 | |
Gain on amendment to tax receivable agreement | ||||||
0 | 0 | - | - | - | - | |
Tax receivable agreement (expense) benefit | ||||||
2,400 | 0 | - | 119,911 | 0 | 0 | |
Interest expense, net | ||||||
-178,900 | -147,000 | - | -100,980 | -62,101 | -32,929 | |
(Loss) income before income taxes | ||||||
54,600 | -69,200 | - | -76,137 | -11,294 | 25,297 | |
Income tax (benefit) expense | ||||||
9,500 | 26,400 | - | -148,982 | 15,758 | 7,570 | |
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | ||||||
45,100 | -95,600 | - | 72,845 | -27,052 | 17,727 | |
Less: Net income attributable to non-controlling interests | ||||||
119,900 | 110,100 | - | 71,416 | 38,845 | 26,789 | |
Net loss attributable to Surgery Partners, Inc. | ||||||
-74,800 | -205,700 | - | 1,429 | -65,897 | -9,062 | |
Less: Amounts attributable to participating securities | ||||||
35,700 | 32,400 | - | - | - | - | |
Net loss attributable to common stockholders | ||||||
-110,500 | -238,100 | - | - | - | - | |
Net loss per share attributable to common stockholders - basic and diluted (in USD per share) | ||||||
-2.29 | -4.96 | - | - | - | - | |
Weighted average common shares outstanding - basic and diluted (shares) | ||||||
48,280 | 48,028 | - | - | - | - | |
Net loss per share attributable to common stockholders | ||||||
Basic (in USD per share) | ||||||
- | - | - | 0.04 | -2.04 | -0.28 | |
Diluted (in USD per share) | ||||||
- | - | - | 0.04 | -2.04 | -0.28 | |
Weighted average common shares outstanding | ||||||
Basic (shares) | ||||||
- | - | - | 36,066 | 32,295 | 31,815 | |
Diluted (shares) | ||||||
- | - | - | 37,464 | 32,295 | 31,815 | |
Predecessor | ||||||
Revenues | ||||||
- | - | 1,145,438 | - | - | - | |
Salaries and benefits | ||||||
- | - | 357,175 | - | - | - | |
Supplies | ||||||
- | - | 269,239 | - | - | - | |
Professional and medical fees | ||||||
- | - | 81,185 | - | - | - | |
Lease expense | ||||||
- | - | 52,147 | - | - | - | |
Other operating expenses | ||||||
- | - | 61,450 | - | - | - | |
Cost of revenues | ||||||
- | - | 821,196 | - | - | - | |
General and administrative expenses | ||||||
- | - | 60,246 | - | - | - | |
Depreciation, Depletion and Amortization | ||||||
- | - | 39,551 | - | - | - | |
Provision for doubtful accounts (see Note 1) | ||||||
- | - | 24,212 | - | - | - | |
Income from equity investments | ||||||
- | - | 4,764 | - | - | - | |
Loss on disposals and deconsolidations, net | ||||||
- | - | -2,355 | - | - | - | |
Transaction and integration costs | ||||||
- | - | 8,738 | - | - | - | |
Asset Impairment Charges | ||||||
- | - | 0 | - | - | - | |
Gain (Loss) on Extinguishment of Debt | ||||||
- | - | -11,876 | - | - | - | |
Gain (Loss) Related to Litigation Settlement | ||||||
- | - | 14,101 | - | - | - | |
Business Combination, Gain (Loss) On Acquisition Escrow | ||||||
- | - | 0 | - | - | - | |
Other (income) expense | ||||||
- | - | -353 | - | - | - | |
Total operating expenses | ||||||
- | - | 948,956 | - | - | - | |
Operating income | ||||||
- | - | 196,482 | - | - | - | |
Gain on amendment to tax receivable agreement | ||||||
- | - | 0 | - | - | - | |
Tax receivable agreement benefit (expense) | ||||||
- | - | 3,733 | - | - | - | |
Interest Income (Expense), Nonoperating, Net | ||||||
- | - | -100,571 | - | - | - | |
(Loss) income before income taxes | ||||||
- | - | 92,178 | - | - | - | |
Income Tax Expense (Benefit) | ||||||
- | - | 7,095 | - | - | - | |
Net (loss) income | ||||||
- | - | 85,083 | - | - | - | |
Net Income (Loss) Attributable to Noncontrolling Interest | ||||||
- | - | 75,630 | - | - | - | |
Net Income (Loss) Attributable to Parent | ||||||
- | - | 9,453 | - | - | - | |
Less: Amounts attributable to participating securities | ||||||
- | - | 0 | - | - | - | |
Net (loss) income attributable to common stockholders | ||||||
- | - | 9,453 | - | - | - | |
Basic (in USD per share) | ||||||
- | - | 0.20 | - | - | - | |
Diluted (in USD per share) | ||||||
- | - | 0.20 | - | - | - | |
Weighted Average Number of Shares Outstanding, Basic | ||||||
- | - | 48,018 | - | - | - | |
Weighted Average Number of Shares Outstanding, Diluted | ||||||
- | - | 48,190 | - | - | - | |